Health Care
ADAPTIVE BIOTECHNOLOGIES ADPT
$28.90
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1336 by number of owners
% of all portfolios
0.00%
Rank #1302 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of Polen Capital's portfolio
Live price
Compare with the quarter-end price of $28.90 reported in the 13F
Superinvestors holding ADPT
| Recent activity | |||
|---|---|---|---|
| Polen Capital · Polen Capital Management | 0.0% | ▲ Add+36.8% | $4.1M |